Tissue oxygen saturation measurement during arterial desaturation study

Medtronic Inc0 个研究点目标入组 33 人开始时间: 2019年9月9日最近更新: 2020年6月15日

试验速览

暂无简介。

•1. Subject must be = 18 years old
•2. Subject (or subject’s legally authorized representative) is willing and able to provide written informed consent
•3. Sleep Apnea cohort: subjects undergoing a scheduled SOC sleep study who are expected to experience a minimum of 5% arterial oxygen desaturation
•4. COPD/PAH/HF cohort: subjects undergoing a scheduled SOC 6MWT who are expected to experience a minimum of 5% arterial oxygen desaturation

•1. Subject has other medical conditions that would limit study participation (per physician discretion)
•2. Subject has known allergies to medical adhesives and cannot tolerate placement of NoninTM SenSmartTM EQUANOXTM Advance sensor on chest
•3. Subject has a disorder causing poor blood circulation to the fingers or a connective tissue disorder that would interfere with an accurate measurement of SpO2 in the fingers (per physician discretion)
•4. Subject is unable or unwilling to participate in study procedures
•5. Subject is enrolled in a concurrent study that may confound the results of this study. Co-enrollment is any concurrent clinical study (including registries) requires approval of the study manager or designee
•6. Subject with exclusion criteria required by local law

发起方